|
132
|
380
|
7rxvA |
Human methionine adenosyltransferase 2a bound to methylthioadenosine, malonate (mla) and mgf3 |
|
236
|
948
|
6xrnA |
Crystal structure of human pi3k-gamma in complex with compound 17 |
|
310
|
946
|
7jiuA |
Human pi3kdelta in complex with compound 2f |
|
90
|
270
|
7n5oA |
Fragment-based discovery of a novel bruton's tyrosine kinase inhibitor |
|
89
|
270
|
7n5rA |
Fragment-based discovery of a novel bruton's tyrosine kinase inhibitor |
|
90
|
270
|
7n5yA |
Fragment-based drug design of a novel, covalent bruton's tyrosine kinase inhibitor |
|
90
|
270
|
7n5xA |
Fragment-based discovery of a novel bruton's tyrosine kinase inhibitor |
|
75
|
295
|
7lvhA |
Crystal structure of ap2 associated kinase 1 isoform 1 complexed with ligand n-[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]-3-(propan-2-yl)piperidine-2-carboxamide |
|
83
|
297
|
7lviA |
Crystal structure of ap2 associated kinase 1 isoform 1 complexed with ligand (2r)-2-amino-n-[3-methoxy-4- (1,3-oxazol-5-yl)phenyl]-4-methylpentanamide |
|
101
|
328
|
7l1xA |
Structure of human ck2 alpha kinase (catalytic subunit) with the inhibitor 108600. |
|
94
|
308
|
7jxpA |
Egfr kinase (t790m/v948r) in complex with osimertinib and jbj-04-125-02 |
|
86
|
308
|
7k1iA |
Egfr kinase (l858r/v948r) in complex with allosteric inhibitor jbj-09-063 |
|
94
|
308
|
7jxqA |
Egfr kinase (t790m/v948r) in complex with allosteric inhibitor jbj-09-063 |
|
79
|
287
|
7jxhA |
Her2 in complex with jbj-08-178-01 |
|
88
|
308
|
7jxmA |
Egfr kinase (t790m/v948r) in complex with osimertinib and eai045 |
|
85
|
313
|
7jxlA |
Egfr kinase (t790m/v948r) in complex with az5104 |
|
86
|
308
|
7jxwA |
Egfr kinase (t790m/v948r) in complex with osimertinib and jbj-09-063 |
|
89
|
307
|
7k1hA |
Egfr l858r/v948r in complex with osimertinib and allosteric inhibitor jbj-09-063 |
|
88
|
308
|
7jxkA |
Egfr kinase (t790m/v948r) in complex with pf-06747775 and jbj-04-125-02 |
|
88
|
307
|
7jxiA |
Egfr kinase (t790m/v948r) in complex with pf-06747775 |
|
68
|
289
|
7dxlA |
Fragment-based lead discovery of indazole-based compounds as axl kinase inhibitors |
|
117
|
347
|
6ln1A |
A natural inhibitor of dyrk1a for treatment of diabetes mellitus |
|
185
|
697
|
7rbqA |
Co-crystal structure of human prmt9 in complex with mt556 inhibitor |
|
91
|
308
|
7khjA |
Crystal structure of kit kinase domain with a small molecule inhibitor, plx8512 in the dfg-in state |
|
88
|
308
|
7khkA |
Crystal structure of kit kinase domain with a small molecule inhibitor, plx9486 (bezuclastinib) in the dfg-in state |
|
104
|
327
|
7khgA |
Crystal structure of kit kinase domain with a small molecule inhibitor, plx3397 |
|
84
|
372
|
7n7mA |
Crystal structure of pi5p4kiialpha complex with bi-2536 |
|
85
|
372
|
7n7nA |
Crystal structure of pi5p4kiialpha complex with volasertib |
|
85
|
372
|
7n7kA |
Crystal structure of pi5p4kiialpha complex with amppnp |
|
87
|
372
|
7n7jA |
Crystal structure of pi5p4kiialpha complex with amppnp |
|
83
|
372
|
7n7oA |
Crystal structure of pi5p4kiialpha complex with palbociclib |
|
85
|
372
|
7n7lA |
Crystal structure of pi5p4kiialpha complex with bi-d1870 |
|
90
|
308
|
6xl4A |
Egfr(t790m/v948r) in complex with azd9291 and ddc4002 |
|
83
|
268
|
7mckA |
Structure of chk1 10-pt. mutant complex with lrrk2 inhibitor 18 |
|
115
|
400
|
6x10A |
Crystal structure of acetyltransferase eis from mycobacterium tuberculosis in complex with haloperidol |
|
114
|
400
|
6x6iAAA |
Crystal structure of acetyltransferase eis from mycobacterium tuberculosis in complex with inhibitor sgt543 |
|
116
|
400
|
6x6gAAA |
Crystal structure of acetyltransferase eis from mycobacterium tuberculosis in complex with droperidol |
|
106
|
400
|
6x6yAAA |
Crystal structure of acetyltransferase eis from mycobacterium tuberculosis in complex with inhibitor sgt1264 |
|
111
|
399
|
6x7aAAA |
Crystal structure of acetyltransferase eis from mycobacterium tuberculosis in complex with inhibitor sgt572 |
|
81
|
274
|
7k0vA |
Crystal structure of braf in complex with inhibitor gne-0749 |
|
86
|
272
|
6xloA |
Crystal structure of braf in complex with inhibitor |
|
92
|
316
|
6wxnA |
Egfr(t790m/v948r) in complex with ln3844 |
|
1
|
45
|
7ce4B |
Tankyrase2 catalytic domain in complex with k-476 |
|
47
|
162
|
7ce4A |
Tankyrase2 catalytic domain in complex with k-476 |
|
212
|
625
|
7kicA |
Prmt5:mep50 complexed with 5,5-bicyclic inhibitor compound 34 |
|
209
|
625
|
7kibA |
Prmt5:mep50 complexed with 5,5-bicyclic inhibitor compound 4 |
|
202
|
625
|
7kidA |
Prmt5:mep50 complexed with 5,5-bicyclic inhibitor compound 72 |
|
127
|
407
|
6xdfA |
Crystal structure of ire1a in complex with g-4100 |
|
74
|
311
|
7kidB |
Prmt5:mep50 complexed with 5,5-bicyclic inhibitor compound 72 |
|
132
|
404
|
6xdbA |
Crystal structure of ire1a in complex with g-6904 |
